Leclerc, Jacinthe <br/><br/>
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.  [electronic resource] 

 -  Circulation. Cardiovascular quality and outcomes  Oct 2017 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1941-7705 
<br/><br/><label>Standard No.: </label>10.1161/CIRCOUTCOMES.117.003891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin Receptor Antagonists--adverse effects<br/>Antihypertensive Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Biphenyl Compounds<br/>Databases, Factual<br/>Drug Costs<br/>Drug Substitution--adverse effects<br/>Drugs, Generic--adverse effects<br/>Emergency Service, Hospital<br/>Humans<br/>Hypertension--diagnosis<br/>Losartan--adverse effects<br/>Patient Admission<br/>Patient Safety<br/>Population Surveillance<br/>Quebec--epidemiology<br/>Referral and Consultation<br/>Retrospective Studies<br/>Risk Factors<br/>Tetrazoles--adverse effects<br/>Therapeutic Equivalency<br/>Time Factors<br/>Treatment Outcome<br/>Valsartan--adverse effects